Systematic Pharmacology and GEO Database Mining Revealed the Therapeutic Mechanism of Xuefu Zhuyu Decoration for Atherosclerosis Cardiovascular Disease

Background: Xuefu Zhuyu decoration (XFZYD), as a traditional Chinese compound recipe, has been used to treat atherosclerosis cardiovascular disease (ASCVD) for thousands of years in China, but its effective compounds and underlying treatment molecular mechanism remains promiscuous, which severely li...

Full description

Bibliographic Details
Main Authors: Bin Liang, Yang Xiang, Xiaokang Zhang, Chen Wang, Bingyu Jin, Yue Zhao, Fang Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-12-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2020.592201/full
_version_ 1818448498976096256
author Bin Liang
Yang Xiang
Xiaokang Zhang
Chen Wang
Bingyu Jin
Yue Zhao
Fang Zheng
author_facet Bin Liang
Yang Xiang
Xiaokang Zhang
Chen Wang
Bingyu Jin
Yue Zhao
Fang Zheng
author_sort Bin Liang
collection DOAJ
description Background: Xuefu Zhuyu decoration (XFZYD), as a traditional Chinese compound recipe, has been used to treat atherosclerosis cardiovascular disease (ASCVD) for thousands of years in China, but its effective compounds and underlying treatment molecular mechanism remains promiscuous, which severely limits its clinical application.Methods: The effective components and their targets of XFZYD were predicted and screened based on the Traditional Chinese Medicine System Pharmacology (TCMSP) database. The candidate therapeutic targets of ASCVD were screened by Pharmacogenomics Knowledgebase (PharmGKB) and Comparative Toxicogenomics Database (CTD). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses for target proteins were performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) database. Differentially expressed genes were identified using the GEO2R online tool. Molecular docking was performed by Schrodinger software. To assess the efficacy of the prediction, human umbilical vein endothelial cells (HUVECs) treated with the effective compound of XFZYD were used as the in vitro model.Results: A total of 108 effective compounds (including quercetin) and 137 candidate therapeutic targets were identified. Analyzing the relationships among effective compounds, candidate therapeutic targets, and signaling pathways, the therapy mechanisms of XFZYD were mainly reflected in the protection of vascular endothelium, anti-inflammatory, antioxidant stress, etc. Accordingly, we found the effective compound of XFZYD (quercetin) decreased intracellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) expressions and pro-inflammatory cytokines in HUVECs treated with lipopolysaccharide (LPS), and reduced the adhesion function of HUVECs with monocytes. The inhibitor of the predicted target protein (PTGS2) could further reduce the expressions of VCAM-1, ICAM-1, and TNF-α induced by LPS, and inhibit the adhesion function of HUVECs with monocytes, while PTGS2 agonists partially counteracted the protective effect of quercetin.Conclusions: In this study, the effective components and potential therapeutic targets of XFZYD for ASCVD treatment were explored from the perspective of systemic pharmacology. The effective component quercetin was verified to protect endothelial cells by reducing endothelial inflammatory response and impeding the attachment of monocytes against the predicted therapeutic target PTGS2.
first_indexed 2024-12-14T20:20:29Z
format Article
id doaj.art-7394ed767b5d4a28a892f397dfa4b516
institution Directory Open Access Journal
issn 2297-055X
language English
last_indexed 2024-12-14T20:20:29Z
publishDate 2020-12-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj.art-7394ed767b5d4a28a892f397dfa4b5162022-12-21T22:48:44ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2020-12-01710.3389/fcvm.2020.592201592201Systematic Pharmacology and GEO Database Mining Revealed the Therapeutic Mechanism of Xuefu Zhuyu Decoration for Atherosclerosis Cardiovascular DiseaseBin LiangYang XiangXiaokang ZhangChen WangBingyu JinYue ZhaoFang ZhengBackground: Xuefu Zhuyu decoration (XFZYD), as a traditional Chinese compound recipe, has been used to treat atherosclerosis cardiovascular disease (ASCVD) for thousands of years in China, but its effective compounds and underlying treatment molecular mechanism remains promiscuous, which severely limits its clinical application.Methods: The effective components and their targets of XFZYD were predicted and screened based on the Traditional Chinese Medicine System Pharmacology (TCMSP) database. The candidate therapeutic targets of ASCVD were screened by Pharmacogenomics Knowledgebase (PharmGKB) and Comparative Toxicogenomics Database (CTD). Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses for target proteins were performed using the Database for Annotation, Visualization and Integrated Discovery (DAVID) database. Differentially expressed genes were identified using the GEO2R online tool. Molecular docking was performed by Schrodinger software. To assess the efficacy of the prediction, human umbilical vein endothelial cells (HUVECs) treated with the effective compound of XFZYD were used as the in vitro model.Results: A total of 108 effective compounds (including quercetin) and 137 candidate therapeutic targets were identified. Analyzing the relationships among effective compounds, candidate therapeutic targets, and signaling pathways, the therapy mechanisms of XFZYD were mainly reflected in the protection of vascular endothelium, anti-inflammatory, antioxidant stress, etc. Accordingly, we found the effective compound of XFZYD (quercetin) decreased intracellular adhesion molecule 1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) expressions and pro-inflammatory cytokines in HUVECs treated with lipopolysaccharide (LPS), and reduced the adhesion function of HUVECs with monocytes. The inhibitor of the predicted target protein (PTGS2) could further reduce the expressions of VCAM-1, ICAM-1, and TNF-α induced by LPS, and inhibit the adhesion function of HUVECs with monocytes, while PTGS2 agonists partially counteracted the protective effect of quercetin.Conclusions: In this study, the effective components and potential therapeutic targets of XFZYD for ASCVD treatment were explored from the perspective of systemic pharmacology. The effective component quercetin was verified to protect endothelial cells by reducing endothelial inflammatory response and impeding the attachment of monocytes against the predicted therapeutic target PTGS2.https://www.frontiersin.org/articles/10.3389/fcvm.2020.592201/fullsystematic pharmacologyXuefu Zhuyu decorationatherosclerosis cardiovascular diseasetherapeutic mechanismGEO database
spellingShingle Bin Liang
Yang Xiang
Xiaokang Zhang
Chen Wang
Bingyu Jin
Yue Zhao
Fang Zheng
Systematic Pharmacology and GEO Database Mining Revealed the Therapeutic Mechanism of Xuefu Zhuyu Decoration for Atherosclerosis Cardiovascular Disease
Frontiers in Cardiovascular Medicine
systematic pharmacology
Xuefu Zhuyu decoration
atherosclerosis cardiovascular disease
therapeutic mechanism
GEO database
title Systematic Pharmacology and GEO Database Mining Revealed the Therapeutic Mechanism of Xuefu Zhuyu Decoration for Atherosclerosis Cardiovascular Disease
title_full Systematic Pharmacology and GEO Database Mining Revealed the Therapeutic Mechanism of Xuefu Zhuyu Decoration for Atherosclerosis Cardiovascular Disease
title_fullStr Systematic Pharmacology and GEO Database Mining Revealed the Therapeutic Mechanism of Xuefu Zhuyu Decoration for Atherosclerosis Cardiovascular Disease
title_full_unstemmed Systematic Pharmacology and GEO Database Mining Revealed the Therapeutic Mechanism of Xuefu Zhuyu Decoration for Atherosclerosis Cardiovascular Disease
title_short Systematic Pharmacology and GEO Database Mining Revealed the Therapeutic Mechanism of Xuefu Zhuyu Decoration for Atherosclerosis Cardiovascular Disease
title_sort systematic pharmacology and geo database mining revealed the therapeutic mechanism of xuefu zhuyu decoration for atherosclerosis cardiovascular disease
topic systematic pharmacology
Xuefu Zhuyu decoration
atherosclerosis cardiovascular disease
therapeutic mechanism
GEO database
url https://www.frontiersin.org/articles/10.3389/fcvm.2020.592201/full
work_keys_str_mv AT binliang systematicpharmacologyandgeodatabaseminingrevealedthetherapeuticmechanismofxuefuzhuyudecorationforatherosclerosiscardiovasculardisease
AT yangxiang systematicpharmacologyandgeodatabaseminingrevealedthetherapeuticmechanismofxuefuzhuyudecorationforatherosclerosiscardiovasculardisease
AT xiaokangzhang systematicpharmacologyandgeodatabaseminingrevealedthetherapeuticmechanismofxuefuzhuyudecorationforatherosclerosiscardiovasculardisease
AT chenwang systematicpharmacologyandgeodatabaseminingrevealedthetherapeuticmechanismofxuefuzhuyudecorationforatherosclerosiscardiovasculardisease
AT bingyujin systematicpharmacologyandgeodatabaseminingrevealedthetherapeuticmechanismofxuefuzhuyudecorationforatherosclerosiscardiovasculardisease
AT yuezhao systematicpharmacologyandgeodatabaseminingrevealedthetherapeuticmechanismofxuefuzhuyudecorationforatherosclerosiscardiovasculardisease
AT fangzheng systematicpharmacologyandgeodatabaseminingrevealedthetherapeuticmechanismofxuefuzhuyudecorationforatherosclerosiscardiovasculardisease